Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases
暂无分享,去创建一个
K S Kosik | D. Rowitch | K. Kosik | B. Barres | D. Friedmann-Morvinski | I. Verma | E. Huillard | P. Neveu | R. Gill | T. Papagiannakopoulos | C. Liu | I M Verma | J. Dugas | H. Zong | C Liu | D H Rowitch | Inder M. Verma | T Papagiannakopoulos | D Friedmann-Morvinski | P Neveu | J C Dugas | R M Gill | E Huillard | H Zong | B A Barres | Kenneth S. Kosik | David H. Rowitch | Pierre Neveu | Jason C. Dugas | Emmanuelle Huillard | Chong Liu | Hui Zong
[1] L. Chin,et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. , 2007, Genes & development.
[2] R. DePinho,et al. Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. , 2002, Cancer cell.
[3] G. Pan,et al. MicroRNA-145 Regulates OCT4, SOX2, and KLF4 and Represses Pluripotency in Human Embryonic Stem Cells , 2009, Cell.
[4] L. Luo,et al. Mosaic Analysis with Double Markers Reveals Tumor Cell of Origin in Glioma , 2011, Cell.
[5] Miriam Scadeng,et al. Development of a novel mouse glioma model using lentiviral vectors , 2009, Nature Medicine.
[6] Mustafa Sahin,et al. MicroRNA profiling reveals two distinct p53-related human pluripotent stem cell states. , 2010, Cell stem cell.
[7] Erika Pastrana,et al. miR-124 regulates adult neurogenesis in the SVZ stem cell niche , 2009, Nature Neuroscience.
[8] W. Pardridge,et al. Intravenous RNA Interference Gene Therapy Targeting the Human Epidermal Growth Factor Receptor Prolongs Survival in Intracranial Brain Cancer , 2004, Clinical Cancer Research.
[9] S. Vandenberg,et al. PDGFRα-Positive B Cells Are Neural Stem Cells in the Adult SVZ that Form Glioma-like Growths in Response to Increased PDGF Signaling , 2006, Neuron.
[10] Nader Sanai,et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma. , 2010, World neurosurgery.
[11] Jae W. Lee,et al. The microRNA miR-124 antagonizes the anti-neural REST/SCP1 pathway during embryonic CNS development. , 2007, Genes & development.
[12] D. Rowitch,et al. Glioma Stem Cells: A Midterm Exam , 2008, Neuron.
[13] Gail Mandel,et al. Reciprocal actions of REST and a microRNA promote neuronal identity , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[14] M. Rosenblum,et al. Dose-Dependent Effects of Platelet-Derived Growth Factor-B on Glial Tumorigenesis , 2004, Cancer Research.
[15] Alice Shapiro,et al. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. , 2008, Cancer research.
[16] Gerald C. Chu,et al. P53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation , 2008, Nature.
[17] K. Kosik,et al. Specific MicroRNAs Modulate Embryonic Stem Cell–Derived Neurogenesis , 2006, Stem cells.
[18] W. Filipowicz,et al. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? , 2008, Nature Reviews Genetics.
[19] L. Chin,et al. Mutant EGFR is required for maintenance of glioma growth in vivo, and its ablation leads to escape from receptor dependence , 2010, Proceedings of the National Academy of Sciences.
[20] Francesco Tomasello,et al. miR-21 and 221 upregulation and miR-181b downregulation in human grade II–IV astrocytic tumors , 2009, Journal of Neuro-Oncology.
[21] Agnieszka Bronisz,et al. Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. , 2008, Cancer research.
[22] Arturo Alvarez-Buylla,et al. EGF Converts Transit-Amplifying Neurogenic Precursors in the Adult Brain into Multipotent Stem Cells , 2002, Neuron.
[23] Erkki Ruoslahti,et al. Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs , 2010, Science.
[24] D. Louis,et al. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. , 2001, Genes & development.
[25] G. Broggi,et al. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells , 2006, Nature.
[26] H. Horvitz,et al. MicroRNA expression profiles classify human cancers , 2005, Nature.
[27] S. Gabriel,et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.
[28] O. Bogler,et al. Constitutive EGFR signaling confers a motile phenotype to neural stem cells , 2003, Molecular and Cellular Neuroscience.
[29] J. Uhm. Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2009 .
[30] G. Maira,et al. Extensive modulation of a set of microRNAs in primary glioblastoma. , 2005, Biochemical and biophysical research communications.
[31] Reuven Agami,et al. The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. , 2009, Genes & development.
[32] C. Burge,et al. Prediction of Mammalian MicroRNA Targets , 2003, Cell.
[33] E. Olson,et al. Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. , 2010, Cancer cell.
[34] Konstantin Khrapko,et al. A microRNA array reveals extensive regulation of microRNAs during brain development. , 2003, RNA.
[35] Haifan Lin,et al. MicroRNAs: key regulators of stem cells , 2009, Nature Reviews Molecular Cell Biology.
[36] Wei Liu,et al. MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a , 2008, Journal of Molecular Medicine.
[37] Yuri Kotliarov,et al. Prediction of Associations between microRNAs and Gene Expression in Glioma Biology , 2011, PloS one.
[38] R. Henkelman,et al. Identification of human brain tumour initiating cells , 2004, Nature.